Marta Fiocco

13.6k total citations · 1 hit paper
314 papers, 8.6k citations indexed

About

Marta Fiocco is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marta Fiocco has authored 314 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Surgery, 75 papers in Pulmonary and Respiratory Medicine and 65 papers in Oncology. Recurrent topics in Marta Fiocco's work include Sarcoma Diagnosis and Treatment (50 papers), Childhood Cancer Survivors' Quality of Life (37 papers) and Total Knee Arthroplasty Outcomes (34 papers). Marta Fiocco is often cited by papers focused on Sarcoma Diagnosis and Treatment (50 papers), Childhood Cancer Survivors' Quality of Life (37 papers) and Total Knee Arthroplasty Outcomes (34 papers). Marta Fiocco collaborates with scholars based in Netherlands, United States and Germany. Marta Fiocco's co-authors include Hein Putter, Ronald B. Geskus, Rob G. H. H. Nelissen, Liesbeth C. de Wreede, P. D. S. Dijkstra, T. P. M. Vliet Vlieland, Hans Gelderblom, Bart G. Pijls, Michiel A. J. van de Sande and E.R. Valstar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marta Fiocco

289 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tutorial in biostatistics: competing risks and multi‐state models

2006 1.7k citations Hein Putter, Marta Fiocco et al. profile →

Peers

Countries citing papers authored by Marta Fiocco

Since Specialization

Citations

This map shows the geographic impact of Marta Fiocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Fiocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Fiocco more than expected).

Fields of papers citing papers by Marta Fiocco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Fiocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Fiocco. The network helps show where Marta Fiocco may publish in the future.

Co-authorship network of co-authors of Marta Fiocco

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Fiocco. A scholar is included among the top collaborators of Marta Fiocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Fiocco. Marta Fiocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients 2024 ·BMJ Open ·(unknown), Frederiek van den Bos, Marije Slingerland, (unknown), Gerrit‐Jan Liefers, Wilbert B. van den Hout, Marta Fiocco, Arie J. Verschoor, (unknown), Cynthia Holterhues, Danny Houtsma, Anouk Jochems, (unknown), Leti van Bodegom‐Vos, Simon P. Mooijaart, Hans Gelderblom, Frank M. Speetjens, Nienke A. de Glas, Johanneke E. A. Portielje	0
2	Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design 2023 ·European Journal of Cancer ·Annelienke M. van Hulst, Erica L T van den Akker, (unknown), Marta Fiocco, (unknown), Raphaële R. L. van Litsenburg, Saskia M.F. Pluijm, C. Michel Zwaan, Hanneke M. van Santen, Rob Pieters, Andrea W.M. Evers, Martha A. Grootenhuis, Marry M. van den Heuvel‐Eibrink	5
3	Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome 2023 ·BMC Infectious Diseases ·(unknown), (unknown), Peter A. von dem Borne, Nicole M. A. Blijlevens, Dana Chiţu, Martha T. van der Beek, Marta Fiocco, Mark de Boer	2
4	Physical Function and Physical Activity in Older Breast Cancer Survivors: 5-Year Follow-Up from the Climb Every Mountain Study 2023 ·The Oncologist ·(unknown), Gerrit‐Jan Liefers, Marloes G.M. Derks, Esther Bastiaannet, Marta Fiocco, Titia E. Lans, Carmen C. van der Pol, (unknown), (unknown), Onno R. Guicherit, (unknown), J. W. S. Merkus, Thijs van Dalen, Johanneke E.A. Portielje, Nienke A. de Glas	10
5	Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study 2023 ·European Journal of Cancer ·(unknown), Marloes G.M. Derks, (unknown), Nienke A. de Glas, Marta Fiocco, (unknown), (unknown), (unknown), Onno R. Guicherit, Thijs van Dalen, J. W. S. Merkus, Titia E. Lans, Carmen C. van der Pol, Simon P. Mooijaart, Johanneke E.A. Portielje, Gerrit‐Jan Liefers	3
6	Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy 2023 ·Neurology ·Pim B. van der Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Mathilde C.M. Kouwenhoven, Martin J. van den Bent, Martin Taphoorn, Johan A F Koekkoek	2
7	Thyroid Profile in the First Three Months after Starting Treatment in Children with Newly Diagnosed Cancer 2023 ·Cancers ·(unknown), Cor van den Bos, Miranda P. Dierselhuis, Marta Fiocco, A. A. Verrijn Stuart, Eef G.W.M. Lentjes, Sabine Plasschaert, Wim J. E. Tissing, Hanneke M. van Santen	2
8	CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients 2023 ·BMJ Open ·(unknown), (unknown), Alida F. W. van der Steeg, (unknown), F.N.J. Frakking, Marta Fiocco, Cornelis P. van de Ven, Marc H. W. A. Wijnen, Marianne D. van de Wetering	6
9	Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important? 2023 ·JCO Precision Oncology ·Annelienke M. van Hulst, Martha A. Grootenhuis, (unknown), Raphaële R. L. van Litsenburg, (unknown), Bertrand D. van Zelst, Linda Broer, Saskia M.F. Pluijm, Rob Pieters, Marta Fiocco, Erica L T van den Akker, Marry M. van den Heuvel‐Eibrink	2
10	Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice 2022 ·Supportive Care in Cancer ·(unknown), Judith Spijkerman, Marc H. W. A. Wijnen, Idske C. L. Kremer Hovinga, Friederike Meyer‐Wentrup, Alida F. W. van der Steeg, Marianne D. van de Wetering, Marta Fiocco, (unknown), Auke Beishuizen	15
11	Patient Activation During the First 6 Months After the Start of Stroke Rehabilitation 2022 ·Archives of Physical Medicine and Rehabilitation ·(unknown), Sietske J. Tamminga, Marta Fiocco, (unknown), (unknown), (unknown), T. P. M. Vliet Vlieland, Daniëlla M. Oosterveer	3
12	Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease 2021 ·Clinical Cancer Research ·(unknown), (unknown), Lily Zappeij‐Kannegieter, Lieke M. J. van Zogchel, Marta Fiocco, Max M. van Noesel, Johannes H. M. Merks, C. Ellen van der Schoot, Godelieve A.M. Tytgat, Janine Stutterheim	11
13	Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas 2021 ·European Journal of Cancer ·(unknown), Saskia Litière, Anouk Neven, (unknown), Ian Judson, Patrick Schöffski, Eva Wardelmann, Silvia Stacchiotti, Lorenzo D’Ambrosio, Sandrine Marréaud, Winette T.A. van der Graaf, Bernd Kasper, Marta Fiocco, Hans Gelderblom	7
14	Smell and taste function in childhood cancer patients: a feasibility study 2020 ·Supportive Care in Cancer ·Mirjam van den Brink, (unknown), (unknown), Marta Fiocco, Remco C. Havermans, Wim J. E. Tissing	14
15	Investigating the Relationship Between Age and Kidney Failure in Adults With Category 4 Chronic Kidney Disease 2020 ·Canadian Journal of Kidney Health and Disease ·(unknown), Ngan N. Lam, Ping Liu, Robert R. Quinn, Marta Fiocco, Brenda R. Hemmelgarn, Navdeep Tangri, Marcello Tonelli, Pietro Ravani	7
16	Surprise Question and Performance Status Indicate Urgency of Palliative Care Needs in Patients with Advanced Cancer at the Emergency Department: An Observational Cohort Study 2019 ·Journal of Palliative Medicine ·(unknown), (unknown), Marta Fiocco, Christian Heringhaus, Nanda Horeweg, Yvette M. van der Linden	23
17	End-of-Life Trajectories of Patients With Hematological Malignancies and Patients With Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach 2019 ·American Journal of Hospice and Palliative Medicine® ·(unknown), (unknown), (unknown), Marta Fiocco, A.J. Fogteloo, Christian Heringhaus, Corrie A.M. Marijnen, Nanda Horeweg, Yvette M. van der Linden	28
18	Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution 2018 ·Clinical Cancer Research ·Kathelijne C.J.M. Kraal, Ilse Timmerman, (unknown), Cor van den Bos, József Zsíros, Henk van den Berg, (unknown), Eric Braakman, (unknown), Max M. van Noesel, C. Ellen van der Schoot, Marta Fiocco, Huib N. Caron, Carlijn Voermans, Godelieve A.M. Tytgat	5
19	Causal inference with randomised clinical trials of chemotherapy: The importance of well-documented treatment side-effects 2017 ·Data Archiving and Networked Services (DANS) ·(unknown), Cristian Spitoni, Jakob Anninga, Jeremy Whelan, Matthew R. Sydes, Gordana Jovic, Marta Fiocco	1
20	mstate: An R Package for the Analysis of Competing Risks and Multi-State Models 2011 ·SHILAP Revista de lepidopterología ·Liesbeth C. de Wreede, Marta Fiocco, Hein Putter	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact